Fluvastatin Versus Hepatitis C Virus
This is a dose finding and efficacy trial for fluvastatin versus hepatitis C...
Brief Summary
Official Title: “A Dose Finding Study of Fluvastatin for in Vivo Demonstration of Inhibiting Hepatitis C Replication in Patients Infected With Chronic Hepatitis C”
This is a dose finding and efficacy trial for fluvastatin versus hepatitis C.
- Study Type: Interventional
- Study Design: Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Detailed Clinical Trial Description
Four different oral doses of fluvastatin will be used for 14 days and the viral load of hepatitis C will be measured weekly. This has been extended to different doses for 9-12 weeks.
Intervention(s) in this Clinical Trial
- Drug: fluvastatin
Outcome Measures for this Clinical Trial
Primary Measures
- Viral Load Reduction, Liver test changes
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- HCV RNA positive
Exclusion Criteria:
- Testing positive for alcohol or marijuana
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: 75 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: Bader, Ted, M.D. Other
Overall Clinical Trial Officials and Contacts
Ted Bader, MD Principal Investigator VA Medical Center and University of Oklahoma
Additional Information
Information obtained from ClinicalTrials.gov on February 12, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00441493
Study ID Number: 13035
ClinicalTrials.gov Identifier: NCT00441493
Health Authority: United States: Food and Drug Administration
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00441493
